Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_assertion wasGeneratedBy ECO_0000203 NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_assertion wasDerivedFrom befree-20140225 NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_assertion SIO_000772 16007902 NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_assertion evidence source_evidence_literature NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_assertion description "[In the past 3 months, 7 different studies have Independently described a close association between an activating JAK2 mutation (JAK2V617F) and the classic bcr/abi-negative MPD (ie, polycythemia vera, essential thrombocythemia, myelofibrosis with myeloid metaplasia) as well as the less frequent occurrence of the same mutation in both atypical MPD and the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP317059.RAFNzIpXuF3m8uvk7jHjyotq5cWYYCfmEyuFhfxOk-iX4130_provenance.